Javascript must be enabled to continue!
Pan-cancer DNA methylation signature quantification of lifestyle exposures and cancer prognosis
View through CrossRef
Abstract
Background: Alcohol consumption, body mass index (BMI) and cigarette smoking are among the most well-studied lifestyle cancer risk exposures which can also change the host’s epigenetic methylation patterns. Some of the changes associated with lifestyle exposure are specific and stable over time, thus, can be used to predict and quantify the exposure. Although the link between these lifestyle exposures and increased odds ratio (OR) of different cancer types is well known, their role in predicting cancer survival remains less clear. We hypothesized that by using predicted lifestyle exposures based on the methylation profiles in tumour DNA we could predict the overall survival probability in cancer patients associated with these exposures. Results: The Cancer Genome Atlas (TCGA) Pan-Cancer dataset was used to test the prognostic value of the predicted DNAmethylation (DNAm) alcohol, BMI and smoking exposures in 24 cancer types (n= 8,238 subjects). Multivariable Cox proportional hazards models with adjustment for age, cancer stage and other exposures were used to calculate the hazards ratio (HR) for overall survival associated with these predicted DNAm exposures. We observed specific cancer types with strong associations between poorer survival and higher alcohol consumption (bladder, brain, esophageal, and head and neck cancers), higher BMI (bladder, pancreatic and post-menopausal breast cancers), and smoking (B-cell lymphoma, stomach, bladder and lung cancers). Interestingly, we also observed associations between better survival from kidney cancer with higher alcohol consumption and smoking exposures. For alcohol consumption we found a positive association between HR and OR across all cancers, indicating that for cancers where alcohol is a significant risk factor, it is also associated with poorer survival (p = 0.022). This was not the case for the BMI (p = 0.548) or smoking exposures (p = 0.193). Conclusions: In conclusion, these DNAm exposure signatures may provide novel information on the relationship between these lifestyle factors and cancer outcomes.
Title: Pan-cancer DNA methylation signature quantification of lifestyle exposures and cancer prognosis
Description:
Abstract
Background: Alcohol consumption, body mass index (BMI) and cigarette smoking are among the most well-studied lifestyle cancer risk exposures which can also change the host’s epigenetic methylation patterns.
Some of the changes associated with lifestyle exposure are specific and stable over time, thus, can be used to predict and quantify the exposure.
Although the link between these lifestyle exposures and increased odds ratio (OR) of different cancer types is well known, their role in predicting cancer survival remains less clear.
We hypothesized that by using predicted lifestyle exposures based on the methylation profiles in tumour DNA we could predict the overall survival probability in cancer patients associated with these exposures.
Results: The Cancer Genome Atlas (TCGA) Pan-Cancer dataset was used to test the prognostic value of the predicted DNAmethylation (DNAm) alcohol, BMI and smoking exposures in 24 cancer types (n= 8,238 subjects).
Multivariable Cox proportional hazards models with adjustment for age, cancer stage and other exposures were used to calculate the hazards ratio (HR) for overall survival associated with these predicted DNAm exposures.
We observed specific cancer types with strong associations between poorer survival and higher alcohol consumption (bladder, brain, esophageal, and head and neck cancers), higher BMI (bladder, pancreatic and post-menopausal breast cancers), and smoking (B-cell lymphoma, stomach, bladder and lung cancers).
Interestingly, we also observed associations between better survival from kidney cancer with higher alcohol consumption and smoking exposures.
For alcohol consumption we found a positive association between HR and OR across all cancers, indicating that for cancers where alcohol is a significant risk factor, it is also associated with poorer survival (p = 0.
022).
This was not the case for the BMI (p = 0.
548) or smoking exposures (p = 0.
193).
Conclusions: In conclusion, these DNAm exposure signatures may provide novel information on the relationship between these lifestyle factors and cancer outcomes.
Related Results
Abstract 2094: Correaltions between genome-wide DNA methylation profiles and genomic driver aberrations during multistage lung adenocaricinogenesis
Abstract 2094: Correaltions between genome-wide DNA methylation profiles and genomic driver aberrations during multistage lung adenocaricinogenesis
Abstract
The aim of this study was to clarify correlations between epigenomic and genomic alterations during multistage lung adenocarcinogenesis. Single-CpG resoluti...
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Abstract
Background: Age-associated epigenetic alteration is the underlying cause of DNA damage in aging cells. Two types of youth-associated DNA-protection epigenetic mark...
Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation
Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation
Abstract
Background
DNA methylation is an important type of epigenetic modification involved in gene regulation. Although strong DNA...
Comparative Promoter Methylation Analysis of p53 Target Genes in Urogenital Cancers
Comparative Promoter Methylation Analysis of p53 Target Genes in Urogenital Cancers
<i>Introduction:</i> The methylation status of selected new p53 target genes in bladder, kidney and testicular cancer was investigated to find similarities in methylati...
DNA Methylation in Cancer Epigenetics
DNA Methylation in Cancer Epigenetics
DNA methylation is one of the most important epigenetic modifications next to acetylation or histone modifications, as it has a role in the homeostatic control of the cell and is s...
Global DNA methylation and gene expression analysis in pre-B cell acute lymphoblastic leukemia
Global DNA methylation and gene expression analysis in pre-B cell acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is a hematological cancer associated with precursor B-cells and is the most common cancer diagnosed in children under the age of 15. Our complete...
Correcting Methylation Calls in Clinically Relevant Low-Mappability Regions
Correcting Methylation Calls in Clinically Relevant Low-Mappability Regions
AbstractDNA methylation is an important component in vital biological functions such as embryonic development, carcinogenesis, and heritable regulation. Accurate methods to assess ...
Abstract 1425: Prognostic significance of promoter DNA methylation in patients with neuroblastoma
Abstract 1425: Prognostic significance of promoter DNA methylation in patients with neuroblastoma
Abstract
Background: Neuroblastoma is a genetically heterogenic tumor diagnosed in childhood which exhibits broad clinical diversity ranging from rapid disease progr...

